Logo image of B7E.DE

BLUE CAP AG (B7E.DE) Stock Fundamental Analysis

FRA:B7E - Deutsche Boerse Ag - DE000A0JM2M1 - Common Stock - Currency: EUR

17.5  -0.2 (-1.13%)

Fundamental Rating

4

B7E gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 107 industry peers in the Capital Markets industry. While B7E seems to be doing ok healthwise, there are quite some concerns on its profitability. B7E has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

B7E had negative earnings in the past year.
B7E had a positive operating cash flow in the past year.
B7E had positive earnings in 4 of the past 5 years.
B7E had a positive operating cash flow in each of the past 5 years.
B7E.DE Yearly Net Income VS EBIT VS OCF VS FCFB7E.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

1.2 Ratios

B7E has a worse Return On Assets (-4.39%) than 67.29% of its industry peers.
B7E has a Return On Equity of -13.01%. This is in the lower half of the industry: B7E underperforms 67.29% of its industry peers.
With a Return On Invested Capital value of 1.97%, B7E perfoms like the industry average, outperforming 57.94% of the companies in the same industry.
B7E had an Average Return On Invested Capital over the past 3 years of 4.00%. This is below the industry average of 8.19%.
Industry RankSector Rank
ROA -4.39%
ROE -13.01%
ROIC 1.97%
ROA(3y)-0.43%
ROA(5y)1.69%
ROE(3y)-1.32%
ROE(5y)4.18%
ROIC(3y)4%
ROIC(5y)4.74%
B7E.DE Yearly ROA, ROE, ROICB7E.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

1.3 Margins

Looking at the Operating Margin, with a value of 1.89%, B7E is in line with its industry, outperforming 51.40% of the companies in the same industry.
B7E's Operating Margin has declined in the last couple of years.
The Gross Margin of B7E (49.50%) is better than 66.36% of its industry peers.
In the last couple of years the Gross Margin of B7E has remained more or less at the same level.
Industry RankSector Rank
OM 1.89%
PM (TTM) N/A
GM 49.5%
OM growth 3Y-46.81%
OM growth 5Y-29.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.7%
GM growth 5Y0.6%
B7E.DE Yearly Profit, Operating, Gross MarginsB7E.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, B7E has more shares outstanding
Compared to 5 years ago, B7E has more shares outstanding
B7E has a worse debt/assets ratio than last year.
B7E.DE Yearly Shares OutstandingB7E.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
B7E.DE Yearly Total Debt VS Total AssetsB7E.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 1.96 indicates that B7E is not a great score, but indicates only limited risk for bankruptcy at the moment.
B7E has a better Altman-Z score (1.96) than 64.49% of its industry peers.
The Debt to FCF ratio of B7E is 7.36, which is on the high side as it means it would take B7E, 7.36 years of fcf income to pay off all of its debts.
B7E has a Debt to FCF ratio of 7.36. This is in the better half of the industry: B7E outperforms 73.83% of its industry peers.
A Debt/Equity ratio of 0.78 indicates that B7E is somewhat dependend on debt financing.
The Debt to Equity ratio of B7E (0.78) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 7.36
Altman-Z 1.96
ROIC/WACCN/A
WACCN/A
B7E.DE Yearly LT Debt VS Equity VS FCFB7E.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 1.53 indicates that B7E should not have too much problems paying its short term obligations.
The Current ratio of B7E (1.53) is better than 73.83% of its industry peers.
A Quick Ratio of 1.08 indicates that B7E should not have too much problems paying its short term obligations.
B7E has a Quick ratio of 1.08. This is in the better half of the industry: B7E outperforms 66.36% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.08
B7E.DE Yearly Current Assets VS Current LiabilitesB7E.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

B7E shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.34%.
Looking at the last year, B7E shows a very negative growth in Revenue. The Revenue has decreased by -11.57% in the last year.
The Revenue has been growing by 9.27% on average over the past years. This is quite good.
EPS 1Y (TTM)0.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.23%
Revenue 1Y (TTM)-11.57%
Revenue growth 3Y5.57%
Revenue growth 5Y9.27%
Sales Q2Q%-11.12%

3.2 Future

B7E is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.47% yearly.
B7E is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.12% yearly.
EPS Next Y669.58%
EPS Next 2Y75.36%
EPS Next 3Y51.47%
EPS Next 5YN/A
Revenue Next Year-24.25%
Revenue Next 2Y-12.06%
Revenue Next 3Y-6.86%
Revenue Next 5Y-3.12%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
B7E.DE Yearly Revenue VS EstimatesB7E.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
B7E.DE Yearly EPS VS EstimatesB7E.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 0 2 4 6 8 10

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for B7E. In the last year negative earnings were reported.
B7E is valuated rather expensively with a Price/Forward Earnings ratio of 20.15.
Based on the Price/Forward Earnings ratio, B7E is valued a bit cheaper than 66.36% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.17, B7E is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 20.15
B7E.DE Price Earnings VS Forward Price EarningsB7E.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

B7E's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. B7E is cheaper than 89.72% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of B7E indicates a rather cheap valuation: B7E is cheaper than 93.46% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.17
EV/EBITDA 4.54
B7E.DE Per share dataB7E.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

B7E's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
B7E's earnings are expected to grow with 51.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y75.36%
EPS Next 3Y51.47%

More info and screens

3

5. Dividend

5.1 Amount

B7E has a Yearly Dividend Yield of 3.67%.
Compared to an average industry Dividend Yield of 6.30, B7E pays a bit more dividend than its industry peers.
B7E's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.67%

5.2 History

The dividend of B7E decreases each year by -14.87%.
Dividend Growth(5Y)-14.87%
Div Incr Years0
Div Non Decr Years1
B7E.DE Yearly Dividends per shareB7E.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of B7E are negative and hence is the payout ratio. B7E will probably not be able to sustain this dividend level.
DP-46.81%
EPS Next 2Y75.36%
EPS Next 3Y51.47%
B7E.DE Yearly Income VS Free CF VS DividendB7E.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

More info and screens

BLUE CAP AG

FRA:B7E (6/2/2025, 7:00:00 PM)

17.5

-0.2 (-1.13%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-06 2025-05-06
Earnings (Next)08-20 2025-08-20
Inst Owners25.66%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap78.58M
Analysts82.86
Price Target31.11 (77.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.67%
Yearly Dividend0.45
Dividend Growth(5Y)-14.87%
DP-46.81%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.66%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.15
P/S 0.31
P/FCF 6.17
P/OCF 4.23
P/B 0.98
P/tB 3.05
EV/EBITDA 4.54
EPS(TTM)-2.34
EYN/A
EPS(NY)0.87
Fwd EY4.96%
FCF(TTM)2.83
FCFY16.2%
OCF(TTM)4.13
OCFY23.62%
SpS57.27
BVpS17.92
TBVpS5.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.39%
ROE -13.01%
ROCE 2.89%
ROIC 1.97%
ROICexc 2.45%
ROICexgc 4.07%
OM 1.89%
PM (TTM) N/A
GM 49.5%
FCFM 4.95%
ROA(3y)-0.43%
ROA(5y)1.69%
ROE(3y)-1.32%
ROE(5y)4.18%
ROIC(3y)4%
ROIC(5y)4.74%
ROICexc(3y)4.92%
ROICexc(5y)6.13%
ROICexgc(3y)7.72%
ROICexgc(5y)7.89%
ROCE(3y)5.94%
ROCE(5y)7%
ROICexcg growth 3Y-38.65%
ROICexcg growth 5Y-19.93%
ROICexc growth 3Y-48.01%
ROICexc growth 5Y-26.87%
OM growth 3Y-46.81%
OM growth 5Y-29.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.7%
GM growth 5Y0.6%
F-Score5
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 7.36
Debt/EBITDA 2.1
Cap/Depr 23.33%
Cap/Sales 2.27%
Interest Coverage 0.89
Cash Conversion 62.14%
Profit Quality N/A
Current Ratio 1.53
Quick Ratio 1.08
Altman-Z 1.96
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)27.02%
Cap/Depr(5y)44.24%
Cap/Sales(3y)2.2%
Cap/Sales(5y)2.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.23%
EPS Next Y669.58%
EPS Next 2Y75.36%
EPS Next 3Y51.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.57%
Revenue growth 3Y5.57%
Revenue growth 5Y9.27%
Sales Q2Q%-11.12%
Revenue Next Year-24.25%
Revenue Next 2Y-12.06%
Revenue Next 3Y-6.86%
Revenue Next 5Y-3.12%
EBIT growth 1Y-28.67%
EBIT growth 3Y-43.84%
EBIT growth 5Y-22.68%
EBIT Next Year1172.41%
EBIT Next 3Y105.41%
EBIT Next 5Y55.02%
FCF growth 1Y393.52%
FCF growth 3Y53.59%
FCF growth 5YN/A
OCF growth 1Y527.81%
OCF growth 3Y15.88%
OCF growth 5Y54.35%